CoChat

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Open access

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

Intravenous (IV) subanesthetic doses of ketamine have been shown to reduce psychiatric distress in both major depressive (MDD) and posttraumatic stress disorder (PTSD). However, the effect of ketamine on cognitive function in these disorders is not well understood. To address this gap, we examined the effect of a single dose of IV ketamine on cognition in individuals with MDD and/or PTSD relative to healthy controls (HC). Psychiatric ( n = 29; 15 PTSD, 14 MDD) and sex- age- and IQ matched HC ( n = 29) groups were recruited from the community. A single subanesthetic dose of IV ketamine was administered. Mood and cognitive measures were collected prior to, 2 h and 1 day post-ketamine administration. MDD/PTSD individuals evidenced a large-magnitude improvement in severity of depressive symptoms at both 2-hours and 1 day post-ketamine administration ( p ’s < .001, Cohen d ’s = 0.80–1.02). Controlling for baseline performance and years of education, IV ketamine induced declines in attention (ATTN), executive function (EF), and verbal memory (VM) 2 h post-administration, all of which had resolved by 1 day post-ketamine across groups. The magnitude of cognitive decline was significantly larger in MDD/PTSD relative to HC on attention only ( p = .012, d = 0.56). Ketamine did not affect working memory (WM) performance. Cognitive function (baseline, change from baseline to post-ketamine) was not associated with antidepressant response to ketamine. Results suggest that while ketamine may have an acute deleterious effect on some cognitive domains in both MDD/PTSD and HC individuals, most notably attention, this reduction is transient and there is no evidence of ketamine-related cognitive dysfunction at 1 day post-administration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-021-01327-5

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Mean depression symptom severity scores (self-reported on the Beck Depression Inventory II) across timepoints in healthy control participants (HC) and participants with major depressive disorder (MDD) and posttraumatic stress disorder (PTSD). Error bars indicate 95% confidence intervals. Dotted lines separate categories of depression symptom severity. BDI-II Beck Depression Inventory II.
Fig. 1 Mean depression symptom severity scores (self-reported on the Beck Depression Inventory II) across timepoints in healthy control participants (HC) and participants with major depressive disorder (MDD) and posttraumatic stress disorder (PTSD). Error bars indicate 95% confidence intervals. Dotted lines separate categories of depression symptom severity. BDI-II Beck Depression Inventory II.CC BY · PubMed Central
Fig. 2 Mean and 95% confidence intervals for normalized Cogstate scores/composite scores across the three study timepoints: pre-ketamine (prior to ketamine administration); 2 h post-ketamine; 24 h post-ketamine administration across groups. HC healthy control, MDD major depressive disorder, PTSD posttraumatic stress disorder, IDN identification task, DET detection task, OCL one card learning task, ONB, one-back task, GML Groton maze learning test, ISL International Shopping List. *p < .01.
Fig. 2 Mean and 95% confidence intervals for normalized Cogstate scores/composite scores across the three study timepoints: pre-ketamine (prior to ketamine administration); 2 h post-ketamine; 24 h post-ketamine administration across groups. HC healthy control, MDD major depressive disorder, PTSD posttraumatic stress disorder, IDN identification task, DET detection task, OCL one card learning task, ONB, one-back task, GML Groton maze learning test, ISL International Shopping List. *p < .01.CC BY · PubMed Central
Fig. 3 Mean and SD for change scores at each timepoint relative to baseline for each Cogstate score/composite score. HC healthy control, MDD major depressive disorder, PTSD posttraumatic stress disorder, ATTN attention composite score, WM working memory composite score, EF executive functioning, VM verbal memory. *p < .01.
Fig. 3 Mean and SD for change scores at each timepoint relative to baseline for each Cogstate score/composite score. HC healthy control, MDD major depressive disorder, PTSD posttraumatic stress disorder, ATTN attention composite score, WM working memory composite score, EF executive functioning, VM verbal memory. *p < .01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 3

  1. Cusin C. The Massachusetts General Hospital Guide to Depression (Springer, 2019).
  2. Thase M., Connolly K. R. Ketamine and esketamine for treating unipolar depression in adults: administration, efficacy, and adverse effects. (Wolters Kluwer, 2019).
  3. First, M. B. Structured Clinical Interview for DSM-IV-TR Axis I Disorders: Patient Edition (Biometrics Research Department, Columbia University, 2005).

Cited by

See all 37

Metadata

Authors
Davis, M. T., DellaGiogia, N., Maruff, P., Pietrzak, R. H., & Esterlis, I.
Affiliations
  • United States Department of Veterans Affairs (US)
  • Yale University (US)
Corresponding author
Esterlis, Irina
Venue
Translational Psychiatry
Published
2021-04-08
Volume
11
Issue
1
Pages
205-205
ISSN
2158-3188 (ISSN-L)
OpenAlex
W3145554712
Cited by
37
References
80
Citations by year
2026: 4 · 2025: 5 · 2024: 10 · 2023: 5 · 2022: 11 · 2021: 2
FWCI
4.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1K08MH117351-01, K01MH092681, R01MH104459)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
Keywords
ketamine, major depressive disorder, post-traumatic stress disorder, cognitive function, attention, executive function, verbal memory, working memory, subanesthetic doses, antidepressant response
MeSH terms
Antidepressive Agents, Cognition, Major Depressive Disorder, Humans, Ketamine, Stress Disorders, Post-Traumatic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder. https://app.cochat.ai/papers/10.1038/s41398-021-01327-5
The paper
Davis, M. T., DellaGiogia, N., Maruff, P., Pietrzak, R. H., & Esterlis, I. (2021). Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder. Translational Psychiatry. https://doi.org/10.1038/s41398-021-01327-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.